Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodesix Inc
(NQ:
BDSX
)
1.960
+0.110 (+5.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix Inc
< Previous
1
2
3
4
5
6
7
Next >
Biodesix Awarded U.S. Federal Supply Schedule Contract for Its Comprehensive Lung Cancer Diagnostic Testing Solutions
October 17, 2022
From
Biodesix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 14, 2022
Gainers Imara (NASDAQ:IMRA) stock moved upwards by 37.2% to $3.54 during Friday's pre-market session. The market value of their outstanding shares is at $93.0 million.
Via
Benzinga
Biodesix to Present Data at the CHEST 2022 Annual Meeting Demonstrating High Sensitivity of the Nodify XL2® Blood-Based Lung Nodule Test in Various Patient Populations, Including Individuals Participating in Lung Cancer Screening Programs
October 12, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix: Q2 Earnings Insights
August 04, 2022
Biodesix (NASDAQ:BDSX) reported its Q2 earnings results on Thursday, August 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Biodesix Announces Preliminary Revenue for Third Quarter 2022
October 11, 2022
From
Biodesix, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 29, 2022
Good morning! We're taking a look at the biggest pre-market stock movers traders need to know about on Thursday morning!
Via
InvestorPlace
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
September 09, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.
Via
Benzinga
Recap: Biodesix Q1 Earnings
May 11, 2022
Biodesix (NASDAQ:BDSX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
September 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...
Via
Benzinga
Biodesix to Participate in Two Upcoming Investor Conferences in September
September 06, 2022
From
Biodesix, Inc.
Via
Business Wire
Looking Into Biodesix's Return On Capital Employed
August 22, 2022
Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q2 sales of $10.95 million. Earnings fell to a loss of $15.82 million, resulting in a 1.53% decrease from last quarter.
Via
Benzinga
Biodesix Named a Top 100 Healthcare Technology Company of 2022
August 09, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Second Quarter 2022 Results and Highlights
August 04, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference
August 03, 2022
From
Biodesix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
July 29, 2022
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.
Via
Benzinga
Biodesix to Present Data at IASLC 2022 World Conference Demonstrating that the VeriStrat® Test is Predictive of Progression Free Survival and Overall Survival in Patients with Low or Negative PD-L1 Treated with Immune Checkpoint Inhibitors
July 20, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022
July 19, 2022
From
Biodesix, Inc.
Via
Business Wire
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
July 01, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...
Via
Benzinga
Looking Into Biodesix's Return On Capital Employed
June 15, 2022
Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q1 sales of $6.55 million. Earnings fell to a loss of $15.59 million, resulting in a 17.35% decrease from last quarter.
Via
Benzinga
Biodesix Obtains Medicare Coverage for the Nodify CDT® Lung Nodule Test
June 07, 2022
From
Biodesix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
June 06, 2022
Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 10.2% to $3.56 during Monday's after-market session. The company's market cap stands at $448.5 million.
Via
Benzinga
Biodesix Announces Research Agreement with Top US Cancer Center
June 03, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference
June 01, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference
May 12, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces First Quarter 2022 Results and Highlights
May 11, 2022
From
Biodesix, Inc.
Via
Business Wire
66 Biggest Movers From Yesterday
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 02, 2022
Via
Benzinga
Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022
April 27, 2022
From
Biodesix, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022
April 20, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.